dc.contributor.author |
DeMerle, Kimberley M |
|
dc.contributor.author |
Angus, Derek C |
|
dc.contributor.author |
Baillie, J Kenneth |
|
dc.contributor.author |
Brant, Emily |
|
dc.contributor.author |
Calfee, Carolyn S |
|
dc.contributor.author |
Carcillo, Joseph |
|
dc.contributor.author |
Chang, Chung-Chou H |
|
dc.contributor.author |
Dickson, Robert |
|
dc.contributor.author |
Evans, Idris |
|
dc.contributor.author |
Gordon, Anthony C |
|
dc.contributor.author |
Kennedy, Jason |
|
dc.contributor.author |
Knight, Julian C |
|
dc.contributor.author |
Lindsell, Christopher J |
|
dc.contributor.author |
Liu, Vincent |
|
dc.contributor.author |
Marshall, John C |
|
dc.contributor.author |
Randolph, Adrienne G |
|
dc.contributor.author |
Scicluna, Brendon P |
|
dc.contributor.author |
Shankar-Hari, Manu |
|
dc.contributor.author |
Shapiro, Nathan I |
|
dc.contributor.author |
Sweeney, Timothy E |
|
dc.contributor.author |
Talisa, Victor B |
|
dc.contributor.author |
Tang, Benjamin |
|
dc.contributor.author |
Thompson, B Taylor |
|
dc.contributor.author |
Tsalik, Ephraim L |
|
dc.contributor.author |
van der Poll, Tom |
|
dc.contributor.author |
van Vught, Lonneke A |
|
dc.contributor.author |
Wong, Hector R |
|
dc.contributor.author |
Yende, Sachin |
|
dc.contributor.author |
Zhao, Huiying |
|
dc.contributor.author |
Seymour, Christopher W |
|
dc.date.accessioned |
2021-05-01T14:15:27Z |
|
dc.date.available |
2021-05-01T14:15:27Z |
|
dc.date.issued |
2021-05 |
|
dc.identifier |
00003246-202105000-00004 |
|
dc.identifier.issn |
0090-3493 |
|
dc.identifier.issn |
1530-0293 |
|
dc.identifier.uri |
https://hdl.handle.net/10161/22719 |
|
dc.description.abstract |
Sepsis is defined as a dysregulated host response to infection that leads to life-threatening
acute organ dysfunction. It afflicts approximately 50 million people worldwide annually
and is often deadly, even when evidence-based guidelines are applied promptly. Many
randomized trials tested therapies for sepsis over the past 2 decades, but most have
not proven beneficial. This may be because sepsis is a heterogeneous syndrome, characterized
by a vast set of clinical and biologic features. Combinations of these features, however,
may identify previously unrecognized groups, or "subclasses" with different risks
of outcome and response to a given treatment. As efforts to identify sepsis subclasses
become more common, many unanswered questions and challenges arise. These include:
1) the semantic underpinning of sepsis subclasses, 2) the conceptual goal of subclasses,
3) considerations about study design, data sources, and statistical methods, 4) the
role of emerging data types, and 5) how to determine whether subclasses represent
"truth." We discuss these challenges and present a framework for the broader study
of sepsis subclasses. This framework is intended to aid in the understanding and interpretation
of sepsis subclasses, provide a mechanism for explaining subclasses generated by different
methodologic approaches, and guide clinicians in how to consider subclasses in bedside
care.
|
|
dc.language |
eng |
|
dc.publisher |
Ovid Technologies (Wolters Kluwer Health) |
|
dc.relation.ispartof |
Critical care medicine |
|
dc.relation.isversionof |
10.1097/ccm.0000000000004842 |
|
dc.title |
Sepsis Subclasses: A Framework for Development and Interpretation. |
|
dc.type |
Journal article |
|
duke.contributor.id |
Lindsell, Christopher J|1278336 |
|
duke.contributor.id |
Tsalik, Ephraim L|0373391 |
|
dc.date.updated |
2021-05-01T14:15:26Z |
|
pubs.begin-page |
748 |
|
pubs.end-page |
759 |
|
pubs.issue |
5 |
|
pubs.organisational-group |
School of Medicine |
|
pubs.organisational-group |
Molecular Genetics and Microbiology |
|
pubs.organisational-group |
Medicine, Infectious Diseases |
|
pubs.organisational-group |
Duke |
|
pubs.organisational-group |
Basic Science Departments |
|
pubs.organisational-group |
Medicine |
|
pubs.organisational-group |
Clinical Science Departments |
|
pubs.publication-status |
Accepted |
|
pubs.volume |
49 |
|
duke.contributor.orcid |
Lindsell, Christopher J|0000-0002-3297-2811 |
|
duke.contributor.orcid |
Tsalik, Ephraim L|0000-0002-6417-2042 |
|